[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5808/GI.2010.8.1.041

Gene Expression Analysis for Statin-induced Cytotoxicity from Rat Primary Hepatocytes

Ko, Moon-Jeong (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Ahn, Joon-Ik (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Shin, Hee-Jung (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Kim, Hye-Soo (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Chung, Hye-Joo (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)
Jeong, Ho-Sang (National Institution of Food and Drug Safety Evaluation, Korea Food and Drug Administration)

Publication Information

Abstract

Statins are competitive inhibitors of hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and used most frequently to reduce plasma cholesterol levels and to decrease cardiovascular events. However, statins also have been reported to have undesirable side effects such as myotoxicity and hepatotoxicity associated with their intrinsic efficacy mechanisms. Clinical studies recurrently reported that statin therapy elevated the level of liver enzymes such as ALT and AST in patients suggesting possible liver toxicity due to statins. This observation has been drawn great attention since statins are the most prescribed drugs and statin-therapy was extended to a larger number of high-risk patients. Here we employed rat primary hepatocytes and microarray technique to understand underlying mechanism responsible for statin-induced liver toxicity on cell level. We isolated genes whose expressions were commonly modulated by statin treatments and examined their biological functions. It is of interest that those genes have function related to response to stress in particular immunity and defense in cells. Our study provided the basic information on cellular mechanism of statin-induced cytotoxicity and may serve for finding indicator genes of statin -induced toxicity in rat primary hepatocytes.

Keywords

cytotoxicity; gene expression; hepatocyte; microarray; statin;

Citations & Related Records

Times Cited By KSCI : 1 (Citation Analysis)

Reference
Cited By KSCI

1	Zannis, V.I., Kan, H.Y., Kritis, A., Zanni, E., and Kardassis, D. (2001) .Transcriptional regulation of the human apolipoprotein genes. Front. Biosci. 1, 456-504.
2	Luebke-Wheeler, J., Zhang, K., Battle, M., Si-Tayeb, K., Garrison, W., Chhinder, S., Li, J., Kaufman, R.J., and Duncan, S.A. (2008). HNF4 ${\alpha}$ is implicated in ER stress induced acute phase response by regulating expression of CrebH. Hepatology 48, 1242-1250. DOI
3	Maddrey, W.C. (2005). Drug-induced hepatotoxicity. J. Clin. Gastroenterol. 39, S83-S89. DOI
4	Maitland-van der Zee, A.H., Peters, B.J., Lynch, A.I., Boerwinkle, E., Arnett, D.K., Cheng, S., Davis, B.R., Leiendecker-Foster, C., Ford, C.E., and Eckfeldt, J.H. (2009). The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study. Pharmacogenet. Genomics 19, 338-344. DOI
5	Hart, S.N., Li, Y., Nakamoto, K., Subileau, E.A., Steen, D., and Zhong, X.B. (2010). A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab. Dispos. March 12, [Epub ahead of print] DOI
6	Heart protection study collaborative group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 360, 7-22. DOI
7	Hsu, C.C., Lin, C.C., Liao, T.S., and Yin, M.C. (2006). Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 44, 393-397. DOI
8	Johnston, B., Burns, A.R., Suematsu, M., Issekutz, T.B., Woodman, R.C., and Kubes, P. (1999). Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J. Clin. Invest. 10, 1269-1276.
9	Kanehisa, M., and Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucl. Acids Res. 28, 27-30. DOI
10	Mi, H., Lazareva-Ulitsky, B., Loo, R., Kejariwal, A., Vandergriff, J., Rabkin, S., Guo, N., Muruganujan, A., Doremieux, O., Campbell, M.J., Kitano, H., and Thomas, P.D. (2005). The PANTHER database of protein families, subfamilies, functions and pathways. Nucl. Acids Res. 33, D284-D288. DOI
11	Stein, E., Sprecher, D., Allenby, K.S., Tosiello, R.L., Whalen, E., and Ripa, S.R. (1997). Cerivastatin, a new potent synthetic HMG-CoA reductase inhibitor: Effect of 0.2mg daily in subjects with primary hypercholesterolemia. J. Cardiovasc. Pharmacol. Ther. 2, 7-16. DOI
12	Vasudevan, A.R., Hamirani, Y.S., and Jones, P.H. (2005). Safety of statins: effect on muscle and the liver. Cleve. Clin. J. Med. 72, 990-993. DOI
13	Wilmshurst, P. (2002). Heart Protection Study. Lancet. 2003 Feb 8;361, 528-529 author reply 529-530. DOI
14	Yamazaki, H., Suzuki, M., Alki, T., Morikawa, S., Maejima, T., and Sato, F. (2006). Influence of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors of ubiquinone level in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cell. J. Atheroscler. Thromb. 13, 295-307. DOI
15	Bolego, C., Baetta, R., Bellosta, S., Corsini, A., and Paoletti, R. (2002). Safety Considerations for statins. Curr. Opin. Lipidol. 13, 637-644. DOI
16	Chalasani, N. (2005). Statins and Hepatotoxicity: Focus on patients with fatty liver. Hepatology 41, 690-695. DOI
17	Dold, S., Laschke, M.W., Lavasani, S., Menger, M.D., Jeppsson, B., and Thorlacius, H. (2009). Simvastatin protects against cholestasis-induced liver injury. Br. J. Pharmacol. 156, 466-474. DOI
18	Hamelin, B.A., and Turgeon, J. (1998). Hydrophilicity/lipophilicity: relevance fro the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 19, 26-37. DOI
19	Baycol website. Dear healthcare Letter Baycoll pull.jpg http://www.baycol.com/.
20	Ahn, J., Jeong, K.J., Ko, M., Shin, H.J., Chung, H.J., and Jeong, H. (2009). High-concentration Epigallocatechin gallate treatment causes endoplasmic reticulum stress-mediated cell death in HepG2 cells. Genomics inform. 7, 97-106. DOI
21	Bharadwaj, D., Stein, M.P., Volzer, M., Mold, C., and Du Clos, T.W. (1999). The major receptor for C-reactive protein on leukocytes is fcgamma receptor. J. Exp. Med. 16, 585-590.